Serum Lipidomic Analysis of Colorectal Cancer Patients by Ultrahigh Performance Liquid Chromatography Tandem Q Exactive Orbitrap Mass Spectrometry

CHEN Hong-wei; NONG Yan-ying; ZHU Yi-fan; LIANG Yun-xiao; ZHOU Hai-lin; ZHANG Jia-hao; ZHANG Qi-song

doi:10.19969/j.fxcsxb.21100202

您当前的位置：

首页 >

文章列表页 >

Serum Lipidomic Analysis of Colorectal Cancer Patients by Ultrahigh Performance Liquid Chromatography Tandem Q Exactive Orbitrap Mass Spectrometry

Scientific Papers | 更新时间：2022-07-15

- Serum Lipidomic Analysis of Colorectal Cancer Patients by Ultrahigh Performance Liquid Chromatography Tandem Q Exactive Orbitrap Mass Spectrometry
- Journal of Instrumental Analysis Vol. 41, Issue 7, Pages: 1014-1021(2022)
- 作者机构：
  
  1.广西大学医学院，广西南宁 530004
  2.广西中医药大学附属瑞康医院消化内科，广西南宁 530011
  3.广西壮族自治区人民医院消化内科，广西南宁 530021
- 作者简介：
- 基金信息：
- DOI：10.19969/j.fxcsxb.21100202
  CLC：
扫描看全文
陈鸿炜,农艳瑛,朱一帆等.基于超高效液相色谱－四极杆－静电场轨道阱质谱的结直肠癌患者血清脂质组学研究[J].分析测试学报,2022,41(07):1014-1021.

CHEN Hong-wei,NONG Yan-ying,ZHU Yi-fan,et al.Serum Lipidomic Analysis of Colorectal Cancer Patients by Ultrahigh Performance Liquid Chromatography Tandem Q Exactive Orbitrap Mass Spectrometry[J].Journal of Instrumental Analysis,2022,41(07):1014-1021.
陈鸿炜,农艳瑛,朱一帆等.基于超高效液相色谱－四极杆－静电场轨道阱质谱的结直肠癌患者血清脂质组学研究[J].分析测试学报,2022,41(07):1014-1021. DOI： 10.19969/j.fxcsxb.21100202.

CHEN Hong-wei,NONG Yan-ying,ZHU Yi-fan,et al.Serum Lipidomic Analysis of Colorectal Cancer Patients by Ultrahigh Performance Liquid Chromatography Tandem Q Exactive Orbitrap Mass Spectrometry[J].Journal of Instrumental Analysis,2022,41(07):1014-1021. DOI： 10.19969/j.fxcsxb.21100202.

摘要

该研究采用超高效液相色谱－四极杆－静电场轨道阱质谱结合主成分分析（PCA）、正交偏最小二乘判别分析（OPLS－DA）对结直肠癌（CRC）患者和健康人的各50例血清样本进行脂质组学分析，通过,P,<, 0.05和倍数变化 ,>, 1.5或 ,<, 0.67筛选组间差异脂质，利用受试者工作特征曲线（ROC）验证其诊断能力，为基于脂质组学的CRC筛查提供参考。结果表明，两组血清脂质谱存在明显差异，发现155种差异脂质，以磷脂酰胆碱（PC）和甘油三酯（TAG）为主，涉及磷脂酰胆碱代谢和甘油三酯代谢。筛选并鉴定9个脂质标志物，包括棕榈酰乙醇胺、棕榈酸、鞘氨醇、鞘磷脂（SM）d40∶3、SM d36∶0、TAG 58∶1、PC 34∶2、PC 36∶6、PC 38∶7，其ROC曲线面积（AUC）均大于0.80，特异性与灵敏度较高，对于CRC筛查具有较高的临床诊断价值和应用潜力。

Abstract

Colorectal cancer（CRC） is one of the most malignant tumors in the world and the main cause of cancer death．Traditional diagnostic methods for CRC patients have poor performance owing to their low sensitivity or specificity．The aims of this study are to explore the lipid biomarkers and the metabolic pathways of CRC for better understanding of its pathogenesis as effective and convenient biomarkers for CRC diagnosis are still lacking，and there are relatively few of serum lipidomic study on CRC for the time being．Therefore，the lipidomics analysis on serum samples from 50 normal controls and 50 CRC patients was performed by ultra-high performance liquid chromatography tandem Q Exactive orbitrap mass spectrometry．Lipidomic data was analyzed by univariate statistical analysis，including Mann－Whitney ,U ,or Student’,t ,test and multiple statistical analysis，including principal component analysis（PCA） and orthogonal partial least squares discriminant analysis（OPLS－DA）．In addition，the established OPLS－DA model was validated by 200 times permutation test to exam its fitness and reliability．Through the comparison of lipid profiles，there were significant differences in the serum lipidomics profiles between two groups，and 155 differential lipids were found responsible for their discrimination based on ,P ,<, 0.05 and fold change ,>, 1.5 or ,<, 0.67．Most of them belonged to phosphatidylcholine（PC） and triacylglycerol（TAG） with constituent ratio of 30.32% and 27.10%，respectively，indicating that dysregulation of PC and TAG metabolism could be closely related with CRC formation．Then，the diagnostic ability of differential lipids was evaluated by receiver operating characteristic curve（ROC） analysis．A total of 9 differential lipids with high specificity and sensitivity as well as high diagnostic performance（AUC ,>, 0.80） for CRC diagnosis were selected and identified by using mzCloud and LipidBlast database，including the species of palmitoyl ethanolamide，palmitic acid，sphingosine，sphingomyelin（SM）d40∶3，SM d36∶0，TAG 58∶1，PC 34∶2，PC 36∶6，PC 38∶7．These lipid species，served as the potential diagnostic biomarkers of CRC，exibited a great clinical application potential in serum-based lipidomics screening of CRC．Meanwhile，the study also provided some basic data that could be used to profile the lipid characteristics and explore the mechanism of CRC.

关键词

结直肠癌超高效液相色谱－四极杆－静电场轨道阱质谱脂质组学血清生物标志物

Keywords

colorectal cancerultra-high performance liquid chromatography tandem Q exactive orbitrap mass spectrometrylipidomicsserumbiomarkers

references

Sung H，Ferlay J，Siegel R L，Laversanne M，Soerjomataram I，Jemal A，Bray F．CA Cancer J. Clin.，2021，71：209－249.

Yang Y，Wang Z P，Gao S H，Zhang F，Li M M，Zhong R Q，Chen W S．Chin. J. Pharm. Anal.

杨阳，王志鹏，高守红，张凤，李明明，仲人前，陈万生．药物分析杂志），2018，38（6）：915－926.

Issa I A，Noureddine M. World J. Gastroenterol.，2017，23（28）：5086－5096.

Yang B，Liang Y X，Huang Z S，Tu X，Zhou C Y，Hu Z H，Wen D J，Zhang Q S．J. Instrum. Anal. 杨宝，梁运啸，黄宗声，涂星，周昌园，胡泽华，文德鉴，张淇松．分析测试学报），2022，41（5）：668－674.

Wang R X，Li B W，Lam S M，Shui G H．J. Genet. Genomics，2020，47（2）：69－83.

Silvente－Poirot S，Poirot M．Cancer Sci.，2014，343（6178）：1445－1446.

Poulose N，Amoroso F，Steele R E，Singh R，Ong C W，Mills I G．Nat. Genet.，2018，50（2）：169－171.

Cotte A K，Aires V，Fredon M，Limagne E，Derangere V，Thibaudin M，Humblin E，Scagliarini A，de Barros J P P，Hillon P，Ghiringhelli F，Delmas D．Nat. Commun.，2018，9（1）：322－337.

Wang Y T，Hinz S，Uckermann O，Honscheid P，von Schonfels W，Burmeister G，Hendricks A，Ackerman M J，Baretton G B，Hampe J，Brosch M，Schafmayer C，Shevchenko A，Zeissig S．Biochim. Biophys. Acta Mol. Cell Biol. Lipids，2020，1865（3）：158579.

Zhang L L，Zhu B J，Zeng Y M，Shen H，Zhang J Q，Wang X D．Cancer Lett.，2020，470：75－83.

Shen S S，Yang L，Li L N，Bai Y，Cai C，Liu H W．J. Chromatogr. B，2017，1068/1069：41－48.

Mirnezami R，Spagou K，Vorkas P A，Lewis M R，Kinross J，Want E，Shion H，Goldin R D，Darzi A，Takats Z，Holmes E，Cloarec O，Nicholson J K．Mol. Oncol.，2014，8（1）：39－49.

Kurabe N，Hayasaka T，Ogawa M，Masaki N，Ide Y，Waki M，Nakamura T，Kurachi K，Kahyo T，Shinmura K，Midorikawa Y，Sugiyama Y，Setou M，Sugimura H．Cancer Sci.，2013，104（10）：1295－1302.

Dobrzynska I，Szachowicz－Petelska B，Sulkowski S，Figaszewski Z. Mol. Cell Biochem.，2005，276（1/2）：113－119.

Zhang J J，Zhang L J，Ye X X，Chen L Y，Zhang L T，Gao Y H，Kang J X，Cai C．Prostaglandins Leukot. Essent. Fatty Acids，2013，88（5）：355－360.

Zhao Z W，Xiao Y J，Elson P，Tan H Y，Plummer S J，Berk M，Aung P P，Lavery I C，Achkar J P，Li L，Casey G，Xu Y．J. Clin. Oncol.，2007，25（19）：2696－2701.

Kitamura C，Sonoda H，Nozawa H，Kano K，Emoto S，Murono K，Kaneko M，Hiyoshi M，Sasaki K，Nishikawa T，Shuno Y，Tanaka T，Hata K，Kawai K，Aoki J，Ishihara S．Tumour Biol.，2019，41（5）：1－9.

Taylor L A，Arends J，Hodina A K，Unger C，Massing U．Lipids Health Dis.，2007，6：17－24.

Lupu R，Menendez J A. Curr. Pharm. Biotechnol.，2006，7（6）：483－493.

Liu T，Peng F，Yu J，Tan Z R，Rao T，Chen Y，Wang Y C，Liu Z Q，Zhou H H，Peng J B．Anal. Bioanal. Chem.，2019，411（20）：5079－5088.

Yang M H，Rampal S，Sung J D，Choi Y H，Son H J，Lee J H，Kim Y H，Chang D K，Rhee P L，Kim J J，Rhee J C，Chun H K，Guallar E，Cho J．Am. J. Gastroenterol.，2013，108（5）：833－841.

Kim B C，Shin A，Hong C W，Sohn D K，Han K S，Ryu K H，Park B J，Nam J H，Park J W，Chang H J，Choi H S，Kim J，Oh J H．Cancer Causes Control，2012，23（5）：727－735.

Ulmer H，Borena W，Rapp K，Klenk J，Strasak A，Diem G，Concin H，Nagel G，VHM & PP Study Group．Br. J. Cancer，2009，101（7）：1202－1206.

Coppola J A，Shrubsole M J，Cai Q Y，Smalley W E，Dai Q，Ness R M，Fazio S，Zheng W，Murff H J．Cancer Causes Control，2015，26（4）：635－643.

Alexander J，Gildea L，Balog J，Speller A，McKenzie J，Muirhead L，Scott A，Kontovounisios C，Rasheed S，Teare J，Hoare J，Veselkov K，Goldin R，Tekkis P，Darzi A，Nicholson J，Kinross J，Takats Z．Surg. Endosc.，2017，31（3）：1361－1370.

Mika A，Kobiela J，Czumaj A，Chmielewski M，Stepnowski P，Sledzinski T．Cell Physiol. Biochem.，2017，41（2）：722－730.

Ritchie S A，Heath D，Yamazaki Y，Grimmalt B，Kavianpour A，Krenitsky K，Elshoni H，Takemasa I，Miyake M，Sekimoto M，Monden M，Tomonaga T，Matsubara H，Sogawa K，Matsushita K，Nomura F，Goodenowe D B．BMC Gastroenterol.，2010，10：140－151.

Li F，Qin X Z，Chen H Q，Qiu L，Guo Y M，Liu H，Chen G Q，Song G G，Wang X D，Li F J，Guo S，Wang B H，Li Z L．Rapid Commun. Mass Spectrom.，2013，27（1）：24－34.

Qiu Y P，Cai G X，Zhou B S，Li D，Zhao A H，Xie G X，Li H K，Cai S J，Xie D，Huang C Z，Ge W T，Zhou Z X，Xu L X，Jia W P，Zheng S，Yen Y，Jia W．Clin. Cancer Res.，2014，20（8）：2136－2146.

de Figueiredo Junior A G，Serafim P V P，de Melo A A，Felipe A V，Lo Turco E G，da Silva I D C G，Forones N M．Asian Pac. J. Cancer Prev.，2018，19（5）：1287－1293.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Metabolomic Investigation on Serum of Gout Patients Based on Ultra-high Performance Liquid Chromatography－Quadrupole Time-of-flight Mass Spectrometry

Exploration on Biomarkers for Discrimination of Colorectal Adenoma and Cancer by UHPLC－HRMS-based Serum Metabolomics

Metabolomic Study on Serum of Colorectal Adenoma Patients Based on Ultra-high Performance Liquid Chromatography－ Q Exactive Orbitrap Mass Spectrometry

In Situ Synthesis of Au/Foam Nickel Magnetic Substrate for Rapid Detection of Immunosuppressive Drug Metabolites in Serum by Using Surface Enhanced Raman Scattering Spectroscopy

Determination of Free Thyroid Hormones in Serum by Gel Filtration Chromatography Combined with Liquid Chromatography-Tandem Mass Spectrometry

Related Author

No data

Related Institution

Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases（Hubei Minzu University）

Chinese Medicinal Materials Products Quality Supevision and Inspection Center in Wuling Mountainous Area，Hubei Minzu University

Medical School，Hubei Minzu University

Clinical Laboratory，Enshi City Maternal and Child Health Centre

Department of Medical Laboratory，Affiliated Minda Hospital of Hubei University for Nationalities

Address：100 Xianlie Middle Road, Guangzhou Postal code：510070
Tel：020-87684776,37656606 Fax：020-87684776 Email：fxcsxb@china.com
Technical support is provided by Beijing Founder electronics co., LTD 粤ICP备12017312号-3 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰